These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15111683)

  • 21. The weight of evidence for ropinirole in restless legs syndrome.
    Trenkwalder C
    Eur J Neurol; 2006 Oct; 13 Suppl 3():21-30. PubMed ID: 16930379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Retrospective, Pooled Suicidality Evaluation of Ropinirole Immediate Release and Controlled Release for the Treatment of Restless Legs Syndrome.
    Makumi CW; Paska W; Rolfe K; Shulman KJ
    Clin Ther; 2015 May; 37(5):1122-7. PubMed ID: 25869628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
    Allen R; Becker PM; Bogan R; Schmidt M; Kushida CA; Fry JM; Poceta JS; Winslow D
    Sleep; 2004 Aug; 27(5):907-14. PubMed ID: 15453549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ropinirole: for the treatment of restless legs syndrome.
    Cheer SM; Bang LM; Keating GM
    CNS Drugs; 2004; 18(11):747-54; discussion 755-6. PubMed ID: 15330688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.
    Happe S; Sauter C; Klösch G; Saletu B; Zeitlhofer J
    Neuropsychobiology; 2003; 48(2):82-6. PubMed ID: 14504416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to ropinirole in restless legs syndrome is independent of baseline serum ferritin.
    Morgan JC; Ames M; Sethi KD
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):964-5. PubMed ID: 18645218
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.
    Trenkwalder C; Hundemer HP; Lledo A; Swieca J; Polo O; Wetter TC; Ferini-Strambi L; de Groen H; Quail D; Brandenburg U;
    Neurology; 2004 Apr; 62(8):1391-7. PubMed ID: 15111679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Nausea and Vomiting in Adults Using Ropinirole: A Systematic Review and Meta-Analysis.
    Kurin M; Bielefeldt K; Levinthal DJ
    Dig Dis Sci; 2018 Mar; 63(3):687-693. PubMed ID: 29383607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ropinirole (Requip) for restless legs syndrome.
    Med Lett Drugs Ther; 2005 Aug; 47(1214):62-4. PubMed ID: 16052162
    [No Abstract]   [Full Text] [Related]  

  • 33. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release.
    Pellecchia MT; Vitale C; Sabatini M; Longo K; Amboni M; Bonavita V; Barone P
    Clin Neuropharmacol; 2004; 27(4):178-81. PubMed ID: 15319704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer dopamine agonists in the treatment of restless legs syndrome.
    Weimerskirch PR; Ernst ME
    Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
    Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R;
    Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks.
    García-Borreguero D; Högl B; Ferini-Strambi L; Winkelman J; Hill-Zabala C; Asgharian A; Allen R
    Mov Disord; 2012 Feb; 27(2):277-83. PubMed ID: 22328464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ropinirole in the treatment of restless legs].
    Hellebek A; Kampmann JP
    Ugeskr Laeger; 2005 Jun; 167(23):2541; author reply 2541-2. PubMed ID: 16008015
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse effects of ropinirole-treated restless leg syndrome (RLS) during smoking cessation.
    Juergens TM
    J Clin Sleep Med; 2008 Aug; 4(4):371-2. PubMed ID: 18763430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
    Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
    Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.